Biblio Discovery — Demo Discovery Service

444 hasil

Menampilkan 1–20 · 0,28 detik · RSS

Jurnal

Биопрепараты: Профилактика, диагностика, лечение

Scopus

ISSN 2221-996X · Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» · 444 artikel di indeks

  1. Artikel Jurnal

    Bifunctional hybrid proteins Z-mHoneydew and Z-CyOFP1 based on the Z-domain of Staphylococcus aureus protein A for immunofluorescence assay of immunoglobulins G in blood serum

    A. M. Eliseykin; I. V. Margatskiy; V. E. Artemov dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 2 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. Traditional methods for detecting serum IgG rely on antibodies chemically conjugated to enzymatic or fluorescent tags. The efficiency of such methods may be limited by steric hindrance during chemical cross-linking. As an alternative, bifunctional hybrid proteins Z-mHoneydew and…

  2. Artikel Jurnal

    Preclinical development of pediatric orphan gene therapy medicinal products: Analysis of approaches and challenges (review)

    A. M. Azarova; N. A. Gavrilova; M. V. Tikhomirova

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 2 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. The lack of uniform regulatory requirements for preclinical studies (PCS) of pediatric orphan gene therapy medicinal products (GTMPs) complicates their development and marketing authorization. This review summarizes the key features of PCS for such products and analyzes the successful…

  3. Artikel Jurnal

    Evaluation of the degree of adsorption of vaccine components in diphtheria and tetanus vaccines adsorbed

    E. I. Komarovskaya; K. A. Lysko

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 2 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. The degree of adsorption of vaccine components on the adjuvant determines vaccine efficacy. Requirements for the degree of adsorption of antigen in the finished product have not been established by the WHO, whereas they are regulated in the Russian State pharmacopoeia. These…

  4. Artikel Jurnal

    Tissue specificity and age-related dynamics of CAG promoter activity in rAAV-mediated gene therapy

    R. L. Anisimov; N. V. Nikiforova; E. S. Ivanov dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 2 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. Artificial promoters based on the chicken beta-actin promoter (CAG, CBA, or CB) are frequently used in recombinant adeno-associated virus (rAAV)-based gene therapy products. However, data on the activity and age-related activity dynamic of these promoters remain quite limited. In this…

  5. Artikel Jurnal

    Development of acid alpha-glucosidase-producing clones based on the CHO-K1 cell line

    S. S. Timonova; S. S. Shubina; J. S. Snegireva dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 2 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. The development of a biopharmaceutical drug for enzyme replacement therapy based on recombinant acid α-1,4-glucosidase (α-glucosidase) is a pressing task, the solution of which could provide patients with Pompe disease in the Russian Federation with the necessary amount of the drug…

  6. Artikel Jurnal

    Standardizing microbiological method to detect mycoplasma contamination in biological products: development of Acholeplasma laidlawii PG8 reference standard

    S. M. Sukhanova; Z. E. Berdnikova; O. V. Fadeikina

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. Mycoplasmas are one of the most challenging types of microbial contamination to detect in biological products (BP). Detecting micoplasmas in the BPs and standardizing microbiological control method necessitates highly sensitive culture media and pharmacopeial reference standards (RS)…

  7. Artikel Jurnal

    Two-component vector-based vaccine Ad26.ZEBOV, MVA-BN-Filo against Ebola fever: A review of clinical studies

    L. F. Stovba; O. V. Chukhralya; D. I. Paveliev dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. High reactogenicity of the existing Ebola vaccines necessitates the development of safer and more efficacious alternatives. A solution is to use new recombinant vectorbased vaccines, such as Ad26.ZEBOV (a recombinant vaccine based on non-replicating human Ad26 serotype with an…

  8. Artikel Jurnal

    Long-term stability of liposomal mycobacteriophage D29: A comprehensive in vitro assessment

    V. V. Avdeev; M. B. Lapenkova; M. A. Vladimirsky

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. The spread of antibiotic-resistant mycobacteria necessitates new therapeutic approaches for tuberculosis, phage therapy being one of them. Liposomal mycobacteriophages are considered to be a way to enhance their efficacy; however, a comprehensive assessment of their stability is…

  9. Artikel Jurnal

    Production and functional activity of scFv fragments obtained from recombinant antibodies against influenza virus

    M. A. Plotnikova; V. A. Toporova; E. A. Romanovskaya-Romanko dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. Passive immunotherapy using broad-spectrum antibodies is a promising development vector of new drugs against influenza. However, production process, purification, and storage of clinically suitable recombinant antibodies still face significant challenges. Antibody scFv (single-chain…

  10. Artikel Jurnal

    Effect of primer binding sites mutations on the efficacy of measles virus RNA detection using PCR and LAMP techniques

    G. M. Tsyganova; E. D. Bogoslovskaya; G. A. Shipulin dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. The high variability of the measles virus RNA genome poses risks of mutations accumulating at primer binding sites (complementary binding site), potentially impacting the reliability of molecular measles diagnostics. In this study, we have assessed the impact of such mutations on the…

  11. Artikel Jurnal

    Chikungunya virus-specific pre-existing T cell responses in naïve donors and B cell epitopes in seropositive individuals and experimentally infected mice

    A. A. Nikonova; A. S. Poroshina; T. G. Samartseva dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. Chikungunya virus (CHIKV) poses a major public health challenge in endemic regions due to the lack of specific preventive measures and effective antiviral therapies. Understanding and identifying viral epitopes through rigorous research directly supports the development of more…

  12. Artikel Jurnal

    Lipooligosaccharide in whole-cell pertussis vaccines: Correlation of its content with specific safety parameters in mice

    I. A. Alekseeva; O. V. Shapovalova; G. A. Sapozhnikova dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 2 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. The reactogenicity of whole-cell pertussis vaccines (wPV) is largely attributable to the presence of lipooligosaccharide (LOS), a bacterial endotoxin (BE) from the outer membrane of Bordetella pertussis. Assessing the LOS content in wPV and its correlation with specific safety…

  13. Artikel Jurnal

    Human plasma in the production of medicinal products: national differences in terms of harmonization with global compendial requirements

    О. A. Demidova; O. G. Kornilova; O. V. Muslimova dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. Plasma-derived medicinal products (PDMPs) are used to treat a number of systemic diseases, immunodeficiency disorders, and life-threatening conditions. The growing PDMP consumption necessitates the scaling of production and the provision of a stable supply of plasma, with the quality…

  14. Artikel Jurnal

    Validation of an in vitro biological method for filgrastim potency assessment

    L. A. Gaiderova; M. L. Baykova; O. V. Golovinskaya dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. Filgrastim is a human granulocyte colony-stimulating factor produced using recombinant DNA technology. Since filgrastim quality control necessitates a validated method, establishing the entire method validation parameters is of high priority; confirming the previously established…

  15. Artikel Jurnal

    Specific activity and toxicity of lyophilized recombinant human granulocyte-macrophage colony-stimulating factor (E. coli BL21/pET-GST6His-GM): in vitro and in vivo study

    S. G. Gamaley; G. G. Shimina; E. A. Vyazovaya dkk.

    Биопрепараты: Профилактика, диагностика, лечение, Vol. 26 No. 1 · 2026 · Rusia · DOAJ Scopus

    INTRODUCTION. The development of new effective drugs based on granulocyte-macrophage colony-stimulating factor (GM-CSF) remains a relevant objective: the study of the drug’s biological effects opens new prospects for its clinical use in the treatment of a wide range of diseases – from oncological…